Troriluzole in Adult Participants With Spinocerebellar Ataxia

Clinical trial NCT03701399 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03701399
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Spinocerebellar Ataxias Spinocerebellar Ataxia Type 1 Spinocerebellar Ataxia Type 2 Spinocerebellar Ataxia Type 3 Spinocerebellar Ataxia Type 6 Spinocerebellar Ataxia Type 7 Spinocerebellar Ataxia Type 8 Spinocerebellar Ataxia Type 10

Start date: 2019-03-08
Primary completion: 2022-02-18
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.